34
Participants
Start Date
November 30, 2008
Primary Completion Date
December 31, 2013
Study Completion Date
December 31, 2013
Zyvox - linezolid
Observation and testing in patients for whom their treating physician has determined linezolid is an appropriate therapy. Eye tests performed for subjects who have received linezolid for at least 6 weeks and matching controls who have received other antibiotics for similar types of infections.
Matched control
Matched controls received an antibiotic other than linezolid for at least 6 weeks prior to baseline visit. The control group had only a baseline visit and there were no post baseline study visits.
Associates in Infectious Disease and Tropical Medicine, Pittsburgh
Azienda Ospedaliera Universitaria di San Martino, Genova
Ospedale San Martino, Clinica Malattie Infettive, Genova
Università di Genova, Genova
Drexel University College of Medicine, Partnership Comprehensive Care Practice, Philadelphia
Clinica Malattie Infettive, Azienda Ospedaliero Universitaria Santa Maria della Misericordia, Udine
Triple O Research Institute, PA, West Palm Beach
Henry Ford Health System, Detroit
University of Minnesota, Department of Medicine/Division of Infectious Diseases, Minneapolis
Ochsner Clinic Foundation, New Orleans
St. Bernards Research Center, Jonesboro
Infektionskliniken 1-73, Karolinska Universitetssjukhuset Huddinge, Stockholm
Lead Sponsor
Pfizer
INDUSTRY